Catalyst Pharmaceuticals Inc (CPRX)
21.12
-0.03
(-0.14%)
USD |
NASDAQ |
Nov 21, 16:00
21.12
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Gross Profit Margin (Quarterly): 85.02% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 85.02% |
| June 30, 2024 | 87.45% |
| March 31, 2024 | 87.29% |
| December 31, 2023 | 85.70% |
| September 30, 2023 | 86.20% |
| June 30, 2023 | 87.90% |
| March 31, 2023 | 88.35% |
| December 31, 2022 | 81.57% |
| September 30, 2022 | 83.12% |
| June 30, 2022 | 85.61% |
| March 31, 2022 | 86.33% |
| December 31, 2021 | 80.82% |
| Date | Value |
|---|---|
| September 30, 2021 | 85.23% |
| June 30, 2021 | 87.50% |
| March 31, 2021 | 84.50% |
| December 31, 2020 | 84.30% |
| September 30, 2020 | 86.77% |
| June 30, 2020 | 86.02% |
| March 31, 2020 | 85.75% |
| December 31, 2019 | 85.40% |
| September 30, 2019 | 85.80% |
| June 30, 2019 | 85.22% |
| March 31, 2019 | 86.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
80.82%
Minimum
Dec 2021
88.35%
Maximum
Mar 2023
85.54%
Average
85.73%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 98.43% |
| Vertex Pharmaceuticals Inc | 85.84% |
| Sarepta Therapeutics Inc | 80.37% |
| ADMA Biologics Inc | 49.78% |
| BioVie Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 27.81% |
| Return on Assets | 23.73% |
| Return on Invested Capital | 27.81% |
| Profit Margin (Quarterly) | 34.10% |
| Operating Margin (Quarterly) | 39.56% |
| Return on Net Operating Assets | 53.05% |